DrugDashboards

Olmesartan Medoxomil

olmesartan medoxomil · OLMESARTAN MEDOXOMIL 5 mg/1 · Tablet · Oral · Solco Healthcare US, LLC.

NDC 43547-0299-03 · 30 TABLET in 1 BOTTLE · ANDA · View full market →

The short version

10 companies supply this market — deep enough that no single failure threatens the supply. The price is down 16% over the past year, to $0.0551 per unit. One of its named manufacturing plants, Zhejiang Huahai Pharmaceutical Co., Ltd., failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0551per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$0.2569per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0751per TABweighted avg manufacturer price $0.0429 · Aug 1, 2026136% of what pharmacies pay — higher than 76% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Oct 2023Sep 2026$0.0551
34 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$1.65
#90 count
$4.96

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$4,927
385 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for olmesartan medoxomil (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA206720
TE code
AB
Approval date
Dec 2, 2022
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of olmesartan medoxomil (Tablet)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Direct_rxOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Lifestar Pharma LLCOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Remedyrepack Inc.OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLC.OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLC.OLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Solco Healthcare US, LLC.OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.OLMESARTAN MEDOXOMIL 5 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.OLMESARTAN MEDOXOMIL 20 mg/1Jul 15, 2026Sep 2, 2026
Umedica Laboratories USA Inc.OLMESARTAN MEDOXOMIL 40 mg/1Jul 15, 2026Sep 2, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 5 mg/1Aug 8, 2026Aug 29, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 40 mg/1Aug 8, 2026Aug 29, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 20 mg/1Aug 8, 2026Aug 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olmesartan Medoxomil — NDC 43547-0299-03," retrieved September 3, 2026, https://drugdashboards.com/drug/43547029903.

Free to cite with attribution — see how the data is put together.